Educational Courses

Educational Courses

Trainings – international & local for affiliates, middle & top management and top management, country and regional roles (CEE, West Europe, Middle East, Africa)

Introduction to HTA

COURSE OVERVIEW

Health Technology Assessment (HTA) has been defined by the International Network of Agencies for HTA (INAHTA) as “a multidisciplinary field of policy analysis studying the medical, economic, social, and ethical implications of development, diffusion and use of health technologies (e. g., drugs, devices, surgical procedures, prevention techniques)”. In conducting HTA, the discipline of decision sciences has become increasingly relevant. This introductory course covers the key elements and methods of HTA and combines lectures and discussions.

THE COURSE IS AIMED AT:

  • Healthcare & health policy organizations, National HTA – Agencies
  • Pharmaceutical & medical device industry
  • Academia and research institutions
  • Health insurances/sick funds
  • Consultancy organizations

OBJECTIVES OF COURSE

By the end of the course, participants will be familiar with:
  • HTA principles and practice
  • Methods in biostatistics, clinical epidemiology and EbM
  • Patient-relevant outcome measures
  • Critical study appraisal
  • Systematic reviews & meta-analysis
  • Economic evaluation and pricing
  • Decision-analytic modeling
  • Context-specific application of HTA
  • HTA from different perspectives (agency, industry, etc.)

TOPICS TO BE COVERED:

  1. Key aspects in health technology assessment
  2. Concept of health technology assessment
  3. Key aspects in health technology assessment
  4. Concept of health technology assessment
  5. The role of health technology assessment
  6. Principles of health technology assessment
  7. Pharmacoeconomic aspects of market access
  8. Main steps in HTA dossiers preparation
  9. Selection of clinical trials for inclusion in HTA dossier
  10. Selection of comparators for HTA submissions
  11. Types of economic analysis used in HTA
  12. Budgetary impact analysis
  13. Sensitivity analysis
  14. The role of mah in HTA dossiers preparation
  15. Types and role of threshold
  16. Real life data
  17. Patient registry
  18. Examples related to HTA practice in Bulgaria

DURATION OF THE COURSE:

2 days course, if all topics covered. Please, send your questions to: specify@hta.bg
Epidemiology & Biostatistics

COURSE OVERVIEW

The need for knowledge in the area of epidemiology and biostatistics is becoming increasingly essential in the practice of modern medicine, the handling and creation of scientific information, the participation in multidisciplinary teams working in the field of public health, the management of clinical trials, health insurance, health policy, etc.

The course in epidemiology and biostatistics aims to provide participants with theoretical and practical skills in planning and conducting epidemiological studies, including skills for planning their own research projects using modern methods of
Epidemiology. It also aims to provide expertise in epidemiological analysis as well as theoretical and practical knowledge required for competence in major biostatical analysis.

The course aims to develop practical skills in the participants, so in the program for
each of the three days there are also practical exercises – application of the theory in
practice.

THE COURSE IS AIMED AT:

  • Public health professionals
  • Health policy specialists
  • Medical managers from the pharmaceutical industry
  • Medical managers from the medical devices and diagnostic products industries
  • Specialists in academic and research centers
  • Students and PhD students
  • People working in organizations that run clinical research programs
  • Specialists from health insurance funds
  • Consultancy companies

TOPICS TO BE COVERED:

  1. Introduction to epidemiology
    1. Definition
    2. History
    3. Purpose
    4. Epidemiological approach and epidemiological methods
  2. Types of epidemiological studies
    1. Observational epidemiological studies
      1. Descriptive epidemiological studies
      2. Analytical epidemiological studies
    2. Experimental epidemiological studies
    3. Strengths and weaknesses of the different types of epidemiological studies
    4. Potential errors in conducting of and analysing data frome pidemiological studies
  3. Risk analysis in epidemiological studies
    1. Risk indicators
    2. Causal connection
    3. Public health significance
  4. Data handling
    1. Variables
    2. Frequency
    3. Distribution
    4. Data aggregation methods
    5. Distribution parameters
    6. Sample
  5. Health and disease measures
    1. Coefficient, ratio, index
    2. Incidence, prevalence, mortality
    3. Standardization
  6. Prophylaxis and prevention
    1. Primary
    2. Secondary
    3. Tertiary
    4. Screening
  7. Epidemiology of Infectious Diseases
  8. Epidemiology in Public Health and Health Policy
  9. Critical analysis of publications in the field of epidemiology
  10. Principles of biostatistical analysis and its application in the processing of
    data from epidemiological studies.
  11. Descriptive Biostatistics. Data distribution and dissipation. Frequency tables, frequency
  12. Analytical Biostatistics. Statistical laws, tendencies, mutual relationships, dependencies.
  13. Hypothesis verification. Correlation and regression analysis.
  14. Calculation of risk, chance, relative risk, odds ratio, attribute risk, population attribute risk
  15. Practical activities

DURATION OF THE COURSE:

3 days course, if all topics covered.
Please, send your questions to: specify@hta.bg

Market Access

COURSE OVERVIEW

Market access is a discipline that is increasingly critical to the pharmaceutical sector around the world. The theoretical and practical training of experts from various areas including pharmaceutical industry is increasingly triggered by the rapid development of science, the assessment of health technologies, the various practices in the application of theory, and frequent regulatory changes.

The way senior management manage the risks associated with the introduction of new products to the market also changes. The position of market access manager has significantly changed its meaning and content, its requirements have risen sharply,
requiring an assimilation of new concepts, principles and competencies, as well as close cooperation with all other departments in the company – medical, regulatory, marketing, sales, etc.

This course aims to help managers with the experience of being more effective and successful in achieving their professional goals from the market access perspective. The course will discuss many examples of market access reality.

THE COURSE IS AIMED AT:

The course is suitable for pharmaceutical industry executives with at least 5 years of experience – medical, regulatory, market access, marketing, sales departments.

TOPICS TO BE COVERED:

  1. Current trends in the European drug policy
  2. Basic terminology in the assessment of health technologies
  3. Concept of Health Technology Assessment
  4. Role of Health Technology Assessment
  5. Principles in Health Technology Assessment
  6. Pharmacoeconomic aspects of Market Access
  7. Key steps in the preparation of the HTA dossier
  8. Selection of clinical trials for inclusion in the HTA dossier
  9. Selection of comparators in the HTA dossier
  10. Types of economic analyses in HTA
  11. Budgetary impact analysis
  12. Sensitivity analysis
  13. The role of the MAH in the preparation of the HTA dossier
  14. Type and role of thresholds
  15. Real life data
  16. Patient registers
  17. Various examples from practice.

DURATION OF THE COURSE:

2 days course, if all topics covered.

Please, send your questions to: specify@hta.bg

Pricing and Reimbursement

COURSE OVERVIEW

Pricing is of growing importance and complexity of all effective marketing and corporate strategies. Strategically, pricing has a direct impact on a company’s profitability, long-term sustainability and innovativeness, brand and corporate image, marketing and distribution effectiveness, and customer relationship management.
This course aims to develop awareness about pricing and reimbursement. In a situation of very complex environment in terms of regulations, HTA and pharmacoeconomics, and cost containment measures, the value proposition is of a key importance in order to grant best medication within the existing financial limits. The better understanding of cost/price/value concept, internal and external price referencing and its consequences, price decrease impact on company P&L etc. will enable the team to increase understanding about the added value and the importance of medicinal products which are protecting human life, well-being and productivity.

OBJECTIVES OF COURSE

  • To improve pricing awareness;
  • To shape the perception about price importance
  • Reinforce the execution of the pricing strategies
  • Support communication within the company and with respective local pricing bodies (HAs)
  • Minimize the impact of local pricing regulation
  • Managing different pricing issues

THE COURSE IS AIMED AT MEMBERS OF:

This course is suitable for anyone whose responsibilities/porfolio includes setting prices for their products and services:

  • Executive managers
  • Marketing, product, brand and sales managers, incl. medical department
  • Retail managers
  • Distribution managers
  • Product development managers
  • Business Owners

TOPICS TO BE COVERED:

  1. The ‘concept’ of price
  2. Key drivers of price
  3. The importance of price optimization
  4. Introduction to HTA
  5. The utilization of pharmacoeconomic evaluations
  6. Free market concept
  7. Negotiation with more powerful
  8. Basics of risk management
DURATION OF THE COURSE:

2 days course, if all topics covered.

Please, send your questions to: specify@hta.bg

HTA Beyond Market Access

Course Overview

The course aims to demonstrate to the participants the role of the HTA both during Market Access and after the product’s appearance
and presence on the market. In addition to the clinical benefits of medicinal products and the ways in which these benefits are
measured and their economic side (the costs of these benefits), it is also important to compare these data with data for the
comparators (RWD). But also, when we know these tools well and know how to handle them, they can be at the heart of risk-sharing
agreements (RSAs). The HTA: Beyond Market Access, as Competitive Advantage course aims to capture the role of each member of
the team in the big picture called HTA.
Duration: 2 days course, if all topics covered.

THE COURSE IS AIMED AT:

– Healthcare & health policy organizations, National HTA – Agencies
– Pharmaceutical & medical device industry
– Academia and research institutions
– Health insurances/sick funds
– Consultancy organizations

Topics to be covered:
1. HTA in Market Access
       1.1. Relative efficacy assessment (REA)
       1.2. Pharmacoeconomics
       1.3. Budget impact analysis (BIA)
2. Clinical Studies
       2.1. Selection
       2.2. Strengths & Weaknesses analysis
       2.3. Possible mistakes
3. Real world data (RWD), relative efficacy assessment (REA)
       3.1. Real world data: Principles
       3.2. Real world data: Application
       3.3. Survival analysis
       3.4. Quality assurance in healthcare
4. Pharmacoeconomics
       4.1. Pharmacoeconomics – basics
       4.2. Real world data in pharmacoeconomics
       4.3. Quality of life (QoL). Role of local data

5. Budget impact analysis (BIA)
       5.1. Basics of BIA
       5.2. Real world data in BIA
       5.3. Indication based-pricing
6.Risk-sharing agreements
       6.1. Taxonomy
       6.2. Performance-based risk-sharing agreements – advantages and
disadvantages
       6.3. Financial-based risk-sharing agreements – advantages and
disadvantages
7. Value based Healthcare
       7.1. Outcomes measurement
       7.2. Time-driven activity-based costing
       7.3. Bundle payment
8. Price optimization
       8.1. Role of HTA
       8.2. Role of medical, Market Access, regulatory, marketing

Please, send your questions to: specify@hta.bg

Courses AcadCapacity

Course Overview

The course “Building Academic Capacity for Data Analyses and Outcomes Measurement” is designed to enhance the skills of healthcare professionals in the fields of epidemiology and reproductive dysfunction related to metabolic disorders. This educational initiative aims to develop comprehensive capabilities in systematic data collection, advanced data analysis techniques, and outcomes measurement. The course integrates theoretical knowledge with practical workshops, ensuring participants can apply learned skills in real-world scenarios to improve healthcare delivery and patient outcomes.

  • TOPICS TO BE COVERED
  1. Epidemiology and Epidemiological Studies
    • Collection and analysis of epidemiological data for patients with endocrine diseases.
    • Fundamental concepts and applications of epidemiology in understanding disease patterns and impacts.
  2. Data Processing and Analysis
    • Techniques for analyzing data from epidemiological studies.
    • Use of statistical software for data manipulation and interpretation.
  3. Systematic Literature Review (SLR)
    • Conducting SLRs on research issues related to endocrine diseases and reproductive dysfunction.
    • Identifying gaps in current research and summarizing findings to guide future research.
  4. Meta-Analysis Methodologies
    • Consolidation of data from multiple epidemiological studies.
    • Hands-on training in meta-analysis to synthesize research data effectively.
  5. Outcome Measurement
    • Introduction to outcome measurement concepts tailored to specialty areas.
    • Implementing outcome measurement tools in clinical practice to evaluate treatment effectiveness.
  6. Time-Driven Activity-Based Costing (TDABC)
    • Integrating TDABC into healthcare workflows to improve cost-efficiency and resource utilization.
    • Practical exercises on applying TDABC in clinical settings.
  7. Quality of Life Assessments
    • Evaluating the quality of life of patients with endocrine diseases and reproductive dysfunctions.
    • Tools and methodologies for assessing patient-reported outcomes.
  8. Scientific Writing and Communication
    • Best practices in preparing scientific publications and presentations.
    • Workshops on writing scientific articles and creating posters for academic and professional audiences.


  • THE COURSE IS AIMED AT
    • Healthcare Professionals
    • Public Health Specialists
    • Healthcare Policy-Makers
    • Academic Students and Instructors


  • Duration: 2 days
  • Course format: live course
  • Apply for a course
Courses VBHC

Course Overview

Value in health care is the measured improvement in a person’s health outcomes for the cost of achieving that improvement. Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes. Under value-based care agreements, providers are rewarded for helping patients improve their health, reduce the effects and incidence of chronic disease, and live healthier lives in an evidence-based way. Value-based care differs from a fee-for- service or capitated approach, in which providers are paid based on the amount of healthcare services they deliver. The “value” in value-based healthcare is derived from measuring health outcomes against the cost of delivering the outcomes.

  • TOPICS TO BE COVERED
  1. Introduction to Value-Based Healthcare
  • Understanding Value in Healthcare: Importance of health outcomes relative to costs.
  • Core Concept of VBHC: Enhancing patient outcomes while managing costs.
  1. Principles of Value-Based Healthcare Delivery
    • Patient-Centric Care: Focus on comprehensive care over the full cycle of the medical condition.
    • Integrated Practice Units (IPUs): Explanation of their roles in patient-focused care delivery.
  2. Time-Driven Activity-Based Costing (TDABC)
    • Introduction to TDABC: Methodology and application in healthcare for precise cost measurement.
    • Implementing TDABC: Steps including defining medical conditions, mapping care processes, and calculating costs.
  3. Developing Process Maps for Patient Care
    • Creation of Detailed Process Maps: For each activity in the patient care delivery cycle.
    • Cost Calculation in TDABC: Using time estimates for each care process.
  4. Strategic Agenda for Implementing Value-Based Healthcare
    • Care Re-organization: Delivery around patient medical conditions rather than specialties.
    • Role of Multidisciplinary Teams and IT: Support systems in VBHC.
  5. Measurement of Outcomes and Economic Models
    • Techniques for Measuring Patient Outcomes: That matter to patients.
    • Overview of Economic Models: Such as bundled payments and capitation to fund VBHC.
  6. Challenges and Solutions in Implementing VBHC
    • Identifying Barriers: Like misaligned payment models and systemic resistance.
    • Solutions to Overcome Barriers: Using bundled payments and IPUs.
  7. Healthcare Transformation Through VBHC
    • Case Studies: On healthcare transformation initiatives aligning with VBHC principles.
    • Successful Strategies and Common Pitfalls: Insights into implementation processes.
  8. Innovations and Future Directions in VBHC
    • Innovative Practices within IPUs: Use of advanced analytics and patient data platforms.
    • Impact of Predictive Analytics: On patient care planning and outcome optimization.
  9. Global Perspectives on VBHC
    • Implementations Across Countries: Comparative analysis of VBHC in different health systems.
    • Insights into Various Institutional Frameworks: And their adaptation to VBHC principles.
  • THE COURSE IS AIMED AT: 
  • Public health professionals
  • Medical managers from the pharmaceutical industry
  • Medical managers from the medical devices and diagnostic products industries
  • Specialists in academic and research centers
  • Specialists from health insurance funds
  • Consultancy companies
  • Course format: live course

Apply for a course: yoanna@futurevalues.bg

Upscalemedia transformed

Course Overview

This course aims to equip aspiring entrepreneurs in the healthcare industry with the knowledge and skills necessary to launch and manage a successful business. Participants will learn about the intricacies of the healthcare market, strategic business planning, and operational management to not only provide quality patient care but also ensure the business’s financial health and compliance with legal standards.

  • TOPICS TO BE COVERED

1.Understanding Healthcare Needs and Market Dynamics:

  • Assessing demand, supply, and defining needs in healthcare.
  • Patient journey mapping and improving patient flow management.

2.Organizational Healthcare Management:

  • Strategies for optimizing treatment organization for higher benefits.
  • Designing health services that meet both cost efficiency and quality care standards.

3.Business and Financial Management:

  • Developing effective pricing strategies and alternative payment models.
  • Financial forecasting, cash flow management, and securing startup capital.

4.Sales and Marketing in Healthcare:

  • Techniques for patient recruitment and enhancing sales processes.
  • Creating impactful marketing campaigns tailored to healthcare.

5.Operational Management and Strategic Planning:

  • Employing strategic business planning and understanding the equilibrium point.
  • Short-term and annual vision planning for sustainable business growth.

6.Legal and Ethical Considerations:

  • Navigating the legal landscape of the healthcare business in Bulgaria.
  • Building a business plan that includes ethical considerations and compliance.

7.Human Resource Management:

  • Hiring practices, leadership, and team management.
  • Employee relations and creating a motivated workforce.
  • THE COURSE IS AIMED AT: 
  • Young medical professionals.
  • Healthcare practitioners looking to enhance their entrepreneurial skills.
  • Individuals interested in understanding the business aspects of healthcare.
Apply now!
Shopping Cart